Driver mutations correlating with phenotype and prognosis have become increasingly important in predicting clinical outcomes in patients with myelo......READ MORE
Along with age and history of thrombosis, leukocytosis is an independent risk factor for thrombotic events in patients with polycythemia vera (PV).......READ MORE
Durable count control in patients with polycythemia vera (PV) involves achieving a delicate balance between hematocrit, platelet, and leukocyte cou......READ MORE
The risk of vascular complications in patients with myeloproliferative neoplasms (MPN) may be predicted by older age, history of thrombosis, and ot......READ MORE
